🔴 Natera is trading 5% down in pre-market — no verified catalyst identified

Natera is trading 4.87% down at $372.00, with no verified company-specific catalyst identified for the pre-market decline.

• Natera is scheduled to report third-quarter results after the market closes on November 5; its conference call is at 4:30 p.m. ET. This upcoming event is context, not a confirmed explanation for the move.
• The broader biotechnology sector is reported higher pre-market, and available evidence does not establish a market-wide cause either.